Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
126.00    -2.00 (-1.56%)
Bid:
126.00
Ask:
129.00
Spread: 3.00 (2.381%)
Market Cap: £200.74m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Pre-close Trading Update and Board Change

30 Sep 2015 07:00

RNS Number : 6047A
Redcentric PLC
30 September 2015
 

30 September 2015

Redcentric plc

("Redcentric" or the "Company")

 

Pre-close Trading Update and Board Change

Redcentric plc (AIM:RCN), a leading UK IT managed services provider, announces a pre-close trading update covering the six months to 30 September 2015. The Group expects to announce its interim results on 9 November 2015. The company also announces that Fraser Fisher, currently Chief Operating Officer, is to be appointed Chief Executive Officer of the Company in succession to Tony Weaver, who remains on the Board as a non-executive Director.

Trading highlights

· Trading in line with market expectations

· Continued strong organic growth in recurring revenues

· New business momentum maintained, with some notable £1m plus contract wins

· Calyx integration on plan, full contribution in second half

· Strong cash generation

The strong start to trading noted earlier in the year has continued through the first half, with some significant new contracts augmenting the high levels of recurring revenues, which are in excess of 80% of total revenues. During the first half several significant contracts were won, including five £1m plus contracts with both Government and commercial clients.

The integration of Calyx Managed Services, acquired in April 2015, has progressed to plan. The financial benefits of the acquisition will be felt in full in the second half of the year.

Cash generation remains strong, and the company has substantial headroom in its recently renewed banking facilities.

Board changes

Fraser Fisher, the Chief Operating Officer of the Company, will become the Chief Executive Officer of the Company on publication of the Company's interim results on 9 November 2015, in succession to Tony Weaver, who will remain on the Board as a non-executive Director of the Company.

 

Chris Cole, Chairman of Redcentric commented:

"Redcentric is trading strongly. The high level of recurring revenue, increasing traction in the £1m plus contract market and the successful integration of Calyx all combine to give the Board confidence in the company's prospects.

I will be delighted to welcome Fraser as our new CEO. Fraser has a wealth of operational experience and has already made a significant contribution to the business. I am pleased that Tony Weaver will remain on the Board as a non-executive director, providing business continuity as well as maintaining our important links with MXC Capital who have been supporting the development of Redcentric's successful position in the AIM technology sector".

 

 

Enquiries:

 

 

Redcentric plc Tony Weaver, Chief ExecutiveFraser Fisher, Chief Operating OfficerTim Coleman, Chief Financial Officer

 +44 (0)845 034 1111

 

Numis Securities Limited - Nomad & Joint Broker

Simon Willis / Rupert Krefting / Adrian Trimmings

 +44 (0)20 7260 1000

 

 

finnCap Ltd - Joint Broker

Stuart Andrews / Rhys Williams

+44 (0)20 7220 0500

 

 

MXC Capital Markets LLP - Financial Adviser

Marc Young / Charlotte Stranner

+44 (0)20 7965 8149

 

 

Tulchan

James Macey White / Louise Hogberg / Matt Low

+44 (0)20 7353 4200

 

 

 

 

Ends

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZKLFLEKFEBBK
Date   Source Headline
7th Jul 20257:00 amRNSExercise of Options
23rd Jun 20257:00 amRNSExercise of Options
17th Jun 20257:00 amRNSHolding(s) in Company
28th May 20253:59 pmRNSHolding(s) in Company
27th May 202512:00 pmRNSExercise of Options
27th May 20257:00 amRNSDirectorate Change
14th May 20257:00 amRNSExercise of Options
7th May 20257:00 amRNSTrading Update & CEO Appointment
25th Apr 20257:00 amRNSExercise of Options
3rd Apr 20257:00 amRNSExecutive Director Change
2nd Apr 20257:00 amRNSExercise of Options
21st Mar 20253:00 pmRNSExercise of Options
19th Feb 202512:15 pmRNSHolding(s) in Company
17th Feb 20257:00 amRNSExercise of Options
12th Feb 202511:00 amRNSExercise of Options
6th Feb 20257:00 amRNSHolding(s) in Company
5th Feb 202510:00 amRNSExercise of Options
30th Jan 20257:00 amRNSHolding(s) in Company
29th Jan 20257:00 amRNSExercise of Options
27th Jan 20257:00 amRNSBoard Change
20th Jan 20257:00 amRNSDirectorate Change - Group CEO Appointment
6th Jan 20254:00 pmRNSExercise of Options
13th Dec 20245:00 pmRNSExercise of Options
28th Nov 20247:00 amRNSExercise of Options
20th Nov 20247:00 amRNSHalf Year Results
4th Nov 202411:45 amRNSHolding(s) in Company
4th Nov 202411:30 amRNSHolding(s) in Company
1st Nov 20247:00 amRNSBoard Changes
25th Oct 20247:00 amRNSDirector/PDMR Shareholding
11th Oct 20247:00 amRNSExercise of Options
9th Oct 202410:15 amRNSExercise of Options
8th Oct 20247:00 amRNSSave As You Earn Share Option Scheme
4th Oct 20243:00 pmRNSExercise of Options
2nd Oct 20245:30 pmRNSExercise of Options
2nd Oct 20247:00 amRNSGrant of Options and PDMR Shareholding
1st Oct 20247:00 amRNSExercise of Options
27th Sep 20242:07 pmRNSResult of AGM
2nd Sep 20242:41 pmRNSPublication of Annual Report and Notice of AGM
23rd Aug 20242:36 pmRNSDirector/PDMR Shareholding
22nd Aug 20247:00 amRNSExercise of Options
15th Aug 20247:00 amRNSPreliminary results announcement FY24
8th Aug 20247:00 amRNSNotice of Results
7th Jun 202410:21 amRNSForm 8.5 (EPT/NON-RI)
6th Jun 20244:56 pmPRNStatement regarding Redcentric plc ("Redcentric")
6th Jun 202412:00 pmPRNForm 8.3 - Redcentric Plc
6th Jun 202410:25 amRNSForm 8.5 (EPT/NON-RI)
5th Jun 20242:29 pmRNSForm 8.3 - Redcentric plc
5th Jun 20249:57 amPRNForm 8.3 - Redcentric Plc
5th Jun 20247:00 amRNSForm 8.3 - Redcentric PLC
4th Jun 202412:02 pmPRNForm 8.3 - Redcentric Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.